5QIJ | pdb_00005qij

CRYSTAL STRUCTURE OF MURINE 11B- HYDROXYSTEROIDDEHYDROGENASE COMPLEXED WITH 2-(3-(1-(4- CHLOROPHENYL)CYCLOPROPYL)-[1,2,4]TRIAZOLO[4,3-A]PYRIDIN-8- YL)PROPAN-2-OL


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.65 Å
  • R-Value Free: 
    0.235 (Depositor), 0.241 (DCC) 
  • R-Value Work: 
    0.211 (Depositor), 0.215 (DCC) 
  • R-Value Observed: 
    0.212 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 5QIJ

Ligand Structure Quality Assessment 


This is version 1.4 of the entry. See complete history

Literature

Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11 beta-Hydroxysteroid Dehydrogenase Type 1 (11 beta-HSD-1).

Li, J.Kennedy, L.J.Walker, S.J.Wang, H.Li, J.J.Hong, Z.O'Connor, S.P.Ye, X.Y.Chen, S.Wu, S.Yoon, D.S.Nayeem, A.Camac, D.M.Ramamurthy, V.Morin, P.E.Sheriff, S.Wang, M.Harper, T.W.Golla, R.Seethala, R.Harrity, T.Ponticiello, R.P.Morgan, N.N.Taylor, J.R.Zebo, R.Maxwell, B.Moulin, F.Gordon, D.A.Robl, J.A.

(2018) ACS Med Chem Lett 9: 1170-1174

  • DOI: https://doi.org/10.1021/acsmedchemlett.8b00307
  • Primary Citation Related Structures: 
    5QII, 5QIJ

  • PubMed Abstract: 

    BMS-823778 ( 2 ), a 1,2,4-triazolopyridinyl-methanol derived analog, was identified as a potent and selective inhibitor of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) enzyme (IC 50 = 2.3 nM) with >10,000-fold selectivity over 11β-HSD-2. Compound 2 exhibits robust acute pharmacodynamic effects in cynomolgus monkeys (ED 50 = 0.6 mg/kg) and in diet-induced obese (DIO) mice (ED 50 = 34 mg/kg). Compound 2 also showed excellent inhibition in an ex vivo adipose DIO mouse model (ED 50 = 5.2 mg/kg). Oral bioavailability ranges from 44% to 100% in preclinical species. Its favorable development properties, pharmacokinetics, high adipose-to-plasma concentration ratio, and preclinical pharmacology profile have prompted the evaluation of 2 for the treatment of type 2 diabetes and metabolic syndrome in phase 2 clinical trials.


  • Organizational Affiliation
    • Research & Development, Bristol-Myers Squibb, P.O. Box 5400, Princeton, New Jersey 08543, United States.

Macromolecule Content 

  • Total Structure Weight: 64.64 kDa 
  • Atom Count: 4,339 
  • Modeled Residue Count: 530 
  • Deposited Residue Count: 552 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Corticosteroid 11-beta-dehydrogenase isozyme 1
A, B
276Mus musculusMutation(s): 0 
Gene Names: Hsd11b1Hsd11
EC: 1.1.1.146 (PDB Primary Data), 1.1.1.201 (UniProt)
UniProt
Find proteins for P50172 (Mus musculus)
Explore P50172 
Go to UniProtKB:  P50172
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP50172
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAP

Query on NAP



Download:Ideal Coordinates CCD File
C [auth A],
J [auth B]
NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
C21 H28 N7 O17 P3
XJLXINKUBYWONI-NNYOXOHSSA-N
HJG

Query on HJG



Download:Ideal Coordinates CCD File
D [auth A],
I [auth B],
K [auth B],
L [auth B]
2-{3-[1-(4-chlorophenyl)cyclopropyl][1,2,4]triazolo[4,3-a]pyridin-8-yl}propan-2-ol
C18 H18 Cl N3 O
PTIFVLOBVCIMKL-UHFFFAOYSA-N
SO4

Query on SO4



Download:Ideal Coordinates CCD File
E [auth A]
F [auth A]
G [auth A]
H [auth A]
M [auth B]
E [auth A],
F [auth A],
G [auth A],
H [auth A],
M [auth B],
N [auth B],
O [auth B]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
Binding Affinity Annotations 
IDSourceBinding Affinity
HJG BindingDB:  5QIJ Ki: 380 (nM) from 1 assay(s)
IC50: 600 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.65 Å
  • R-Value Free:  0.235 (Depositor), 0.241 (DCC) 
  • R-Value Work:  0.211 (Depositor), 0.215 (DCC) 
  • R-Value Observed: 0.212 (Depositor) 
Space Group: P 41 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 96.3α = 90
b = 96.3β = 90
c = 198.8γ = 90
Software Package:
Software NamePurpose
HKL-2000data reduction
HKL-2000data scaling
AMoREphasing
BUSTERrefinement
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

  • Released Date: 2018-12-19 
  • Deposition Author(s): Sheriff, S.

Revision History  (Full details and data files)

  • Version 1.0: 2018-12-19
    Type: Initial release
  • Version 1.1: 2019-01-16
    Changes: Data collection, Database references
  • Version 1.2: 2021-05-12
    Changes: Structure summary
  • Version 1.3: 2024-03-06
    Changes: Data collection, Database references
  • Version 1.4: 2026-02-18
    Changes: Refinement description, Structure summary